HealthSpring, Inc. Has Agreed to be Acquired by Cigna Corporation

  • Do you own shares of HealthSpring, Inc. (NYSE: HS)?
  • Did you buy any shares before October 24, 2011?
  • Do you think that the proposed buyout price is too low?
  • Do you want to discuss your rights?

If the answer to these questions is "yes," please contact the deal lawyers at Rigrodsky & Long, P.A. ("R & L") today to schedule a FREE consultation. Just call us, or fill out our contact form so that we can call at your convenience. Your consultation will not create any obligation to use our services at any time.

Contact R & L today to be sure your best interests are being protected.

R & L is national law firm with decades of combined legal experience. R & L is investigating potential claims against the board of directors of HealthSpring, Inc. concerning possible breaches of fiduciary duty and other violations of law related to the Company’s entry into an agreement to be acquired by Cigna Corporation for $55.00 per share.

Click here to read the full press release.

Rigrodsky & Long, P.A. Investigates HealthSpring, Inc.'s Sale to Cigna Corporation for Shareholders

Rigrodsky & Long, P.A. announces that it is investigating potential claims against the board of directors of HealthSpring, Inc. (“HealthSpring” or the “Company”) (NYSE: HS) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s entry into an agreement to be acquired by Cigna Corporation (“Cigna”) in a transaction with an approximate value of approximately $3.8 billion.

Under the proposed agreement, HealthSpring shareholders will receive $55.00 per share in cash for every share of HealthSpring common stock they hold.

The investigation concerns whether HealthSpring’s board of directors adequately shopped the Company to obtain the best price possible for HealthSpring’s shareholders before entering into the agreement with Cigna.  Indeed, as recent as August 2, 2011, the Company announced better-than-expected quarterly results.  Herb Fritch, HealthSpring’s Chairman and CEO, commented: “We are pleased to report a strong second quarter and first six months of the year. The continued favorable utilization environment, coupled with continued progress in our quality and physician engagement strategies, positively impacted results across our Medicare Advantage plans. In addition, negative trends that impacted our stand-alone prescription drug plans in the first quarter have improved, resulting in a better than expected PDP MLR. As a result of these factors, among others, we are increasing our earnings per share guidance for the year.”

If you own the common stock of HealthSpring and purchased your shares before October 24, 2011, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth D. Rigrodsky, Esquire or Noah R. Wortman, Case Development Director, of Rigrodsky & Long, P.A., 919 N. Market Street, Suite 980, Wilmington, Delaware 19801, by telephone at (888) 969-4242, or by e-mail to info@rigrodskylong.com.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.

Attorney advertising.  Prior results do not guarantee a similar outcome.

R & L, with offices in Delaware and New York, litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.

Attorney advertising.  Prior results do not guarantee a similar outcome.

Learn more about R&L:  Visit Our WebsiteOur Firm  |  Our Practice Areas  |  FAQ's

Fill out the form below or call us toll-free at 888-969-4242, for a FREE no-obligation consultation.